載入...
The clinical significance of PD-L1 in advanced gastric cancer is dependent on ARID1A mutations and ATM expression
Whether PD-L1 expression is associated with survival outcomes in gastric cancer (GC) is controversial. The inhibition of the PD-1/PD-L1 pathway is effective against genomically unstable tumors. Hypothesizing that also the clinical significance of PD-L1 might be dependent on the activation of molecul...
Na minha lista:
| 發表在: | Oncoimmunology |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6136851/ https://ncbi.nlm.nih.gov/pubmed/30221053 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1457602 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|